Souhaitez-vous accéder aux communiqués récents ?

The Company achieved Q1 2026 record-breaking results across key metrics, including Paying Circles, Global Net Additions, and Subscription Revenue.

MINNEAPOLIS, May 11, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...

Delivered Revenue Within Guidance Range and Adjusted EBITDA Well Above the High-End of Guidance Range First Quarter Revenue Decline of 1.5% Year-Over-Year; Revenue Growth on a Constant Currency Basis...

Company Closed $26.9 million Land Sale in Second Quarter; Total Land Sales Reach $34.6 million Year-to-Date Company Repurchased 245,399 Shares for $10.0 million, Through April 2026 Cash and Cash...

BERKELEY, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced financial...

Research partnerships with Arizona State University, Rensselaer Polytechnic Institute and Stanford University accelerate the U.S. lab-to-fab innovation pipeline by combining academic insights with...

SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

SOUTHLAKE, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology, and...

SALT LAKE CITY, May 11, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health...

Announced two-trial clinical development strategy for AKY-2519 enabling evaluation in multiple patient segmentsInitiated Phase 1b clinical trial of AKY-2519 in metastatic castration-resistant prostate...